{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-073184","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2026-06-29T21:02:44+00:00","discovered_at":"2026-06-29T21:04:03.165667+00:00","generated_at":"2026-06-29T21:04:20.286533+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Protara Therapeutics CMO Leonardo Viana Nicacio resigns effective June 26, 2026","bullets":["Leonardo Viana Nicacio, M.D., resigned as Chief Medical Officer to pursue other opportunities.","Carla Beckham, M.D., Lead Medical Director and Head of Clinical Development, assumes his duties.","Jacqueline Zummo, Ph.D., Chief R&D Officer, will oversee the clinical development function.","Departure is effective June 26, 2026; no other officer changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-073184","json":"https://secwatch.observer/filing/0001213900-26-073184.json","markdown":"https://secwatch.observer/filing/0001213900-26-073184.md","text":"https://secwatch.observer/filing/0001213900-26-073184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026073184/0001213900-26-073184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026073184/ea0296286-8k_protara.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:04:20.286533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}